Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tedizolid vs Linezolid in Acute Bacterial Skin and Skin Structure Infections
CTR20140216Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tedizolid in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Bayer. Started May 2014; status: completed.
02
Drugs
tedizolid
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on CTR20140216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140216.